Linden Thomas Advisory Services LLC Raises Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

Linden Thomas Advisory Services LLC raised its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 23.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 15,247 shares of the company’s stock after purchasing an additional 2,883 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Astrana Health were worth $481,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. GAMMA Investing LLC purchased a new stake in Astrana Health during the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC purchased a new stake in Astrana Health during the 3rd quarter valued at $35,000. KBC Group NV purchased a new position in shares of Astrana Health in the 3rd quarter worth $70,000. Quarry LP purchased a new position in shares of Astrana Health in the 3rd quarter worth $77,000. Finally, Quest Partners LLC purchased a new position in shares of Astrana Health in the 3rd quarter worth $133,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of research reports. Robert W. Baird raised their price target on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. KeyCorp initiated coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Macquarie upgraded Astrana Health to a “hold” rating in a research note on Monday, December 16th. BTIG Research raised their price target on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Finally, Truist Financial cut their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $63.67.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $37.10 on Monday. The stock has a 50-day simple moving average of $36.68 and a two-hundred day simple moving average of $46.70. Astrana Health, Inc. has a 52-week low of $29.08 and a 52-week high of $63.20. The firm has a market capitalization of $2.09 billion, a PE ratio of 28.54, a P/E/G ratio of 1.46 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $478.71 million for the quarter, compared to the consensus estimate of $462.01 million. During the same period in the previous year, the business earned $0.47 earnings per share. Analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.